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Considerable controversy exists regarding the nature and multiplicity of signals
required forT cell-dependent activation of quiescent B lymphocytes . While some
evidence suggests the antigen andTcell-derived lymphokines are sufficient to drive
this process (1), recent studies indicate that proliferative signals are provided by iso-
lated helperT (Th) cell membranes (2)or intactTh cellsmade incapable ofsecreting
lymphokines by cyclosporinA treatment (3) . Finally, anumber ofvery recent reports
indicate that although requirements forTh recognition of antigenic peptide during
in vitro thymus-dependent immune responses can be obviated by stimulation ofTh
cells with anti-CD3 antibodies, T cell-B cell contact is still required (4-6) . These
data, considered in view of the fact that Th cell antigen receptors and CD4 mole-
cules (7) engage laand our biochemical evidence that Ia moleculescan act as signal
transducers (8), led us to explore the possibility that ligand binding to membrane Ia
(mla) molecules leads to transduction of signals that promote B cell proliferation
and/or differentiation .
Previous studies that bearon the possibilityof mIa-mediated signaling have demon-
strated that soluble anti-Ia antibodies antagonize LPS-inducedB cell proliferation
(9, 10) and promote differentiation of CH12 lymphoma cells to secrete IgM (11) .
These effects are surprising in view of the fact that Ia ligation by Th cells occurs
early in the immune response and appears to be necessary, in the case of small B
cells, for initiation of proliferation (12) . Thus, we hypothesized thataproperly timed
signal through la may lead to proliferation of B cells. To test this hypothesis, we
developed a model system in which quiescent B cells were first primed by exposure
to immunoregulatory molecules they arethought to encounter preceding directT-B
cell interaction and were subsequently exposed to anti-la antibodies before various
biologic parameters were measured . Results demonstrate that Ia binding ligands
provide proliferative signals to appropriately primed normal B cells .
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Materials and Methods
Mice.
￿
Akr and (C578L/6 x DBA2)Fl (BDFI) mice were produced in the NationalJewish
Center animal facility and used in the experiments described at 6-12 wk of age .
Reagents .
￿
Recombinant IL-4 andIL-5 were derivedfrom constitutive supernatants ofIL-4
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and IL-5 structural gene transfectants mIL4X63Ag 8.653 andmIL5X63Ag 8.653 (13) provided
by Dr . Fritz Melchers (Basel Institute for Immunology, Basel, Switzerland) . These cells were
shown to be mycoplasma free using the GenProbe test (GenProbe, San Diego, CA) . Units
of IL-4 and IL-5 were based on induction of la expression in normal B cells (14) and the
BCLI assay kindly performed by Dr . Sue Tonkonogy, respectively . Mixed lymphocyte cul-
ernatants were prepared as previously described (15) . LPS (refined standard endo-
typhimurium, G30/C21) was purchased from RIBI (Hamilton,MT) . Antibodies used
hese studies include monoclonal anti-p. (Bet-2 ; reference ,p 16), anti-H-2K (Ml/42.398; 17)
and anti-I-Adb (D3.137.5.7 ; 14), anti-I-E (14.4.4S), anti-I-ANk (10.3.6, 10.2.16, 40M) (18), 39J
(18) anti-I-Aak (2A2 ; 19), anti-Lyb8 (Cy34 .1.2), anti-Lyb2 (10-1.D.1), anti-B220 (RA3-3A1/
69), anti-IgD (JA12.5 ; 20), and anti-IgG-Fcr (2.4G2 ; 21). Antibodies not referenced are de-
scribed and provided by American Type Culture Collection (Rockville, MD) . All antibodies
were purified by proteinA orproteinG chromatography. Polystyrene plateswere coated with
antibodies by overnight incubation at concentrations noted. Plates were washed extensively
before use.
B Cell Isolation and Culture.
￿
Quiescent B cells (p >1.080) were isolated from spleens ofnormal
adult mice as previously described (20). Cell in this population were >90 0 1o mIg+ and >95%
in Go based on flow cytometric immunofluorescence and acridine orange cell cycle analyses.
Cells were cultured (10'/ml) in complete Iscove's modified Dulbeccds medium containing
100 10 FCS (HyClone, Logan, UT) and 2-ME (5 x 10-5 M).
Assays ofActivation .
￿
Cells were stained with acridine orange and analyzed by flow cytom-
etry as previously described (22) using an Ortho cytofluorgraf 50H with 2150 computer. For
analysis of thymidine uptake, cultures (105/cells/200 Al in 96-well tissue culture plates) were
labeled for 3 h with I ACi [3H]thymidine before being harvested and counted . Ig (IgM and
total IgG) production was assessed using an ELISA (23) . Lymphocyte activation was also
assessed upon theMTT assay ofmitochondial metabolic activity as previously described (24).
Results and Discussion
Based on observations that IL-4 primes B cells for T-B conjugate formation (25)
and proliferation (26, 27), it has been proposed that IL-4, produced during Th
cell/antigen-presentingmacrophage interactions, may provide an important B cell
ignal before T-B interactions. Clearly antigen binding toB cells leads to signal trans-
ion (28-31) and is essential for subsequent antigen processingand presentat
to direct T-B interactions . Therefore, we employed IL4 and mIg binding
ligands, in this case low doses of the monoclonal anti-IgM antibody Bet-2, for B
cell priming. Likethymus dependent antigens, soluble Bet-2 binds to antigen receptors
and induces Ca2' mobilization, phosphoinositide hydrolysis, la expression and
proto-oncogene expression, but is not mitogenic, and thus is an appropriate thymus-
dependent antigen surrogate (28-38 ; Klemsz and Cambier, unpublished observa-
) . It should be noted that for all responses described below, priming with both
ligands was required . In the optimal situation, quiescent B cells were primed 12-16 h
with IL-4 and Bet-2 before being transferred to plastic plates thathad been precoated
with anti-Ia mAbs used as a surrogate for Th cells. As shown in Fig . 1 C, quiescent
B cells that had been primed as described above, underwent an immediate morpho-
logical transformation upon transfer to anti-Ia coated plates. This response, which
was detectable within 10-20 min of cell transfer, was characterized by formation
of extended fibrillar pseudopods . Most B cells (>80%) underwent this transforma-
tion within 6 h of initiation of culture (with anti-Ia) and retained this morphology
ith anti-
MHC class I (M1.42.398, anti-H-2K) antibodies did not undergo this response (Fig.
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FIGURE 1 .
￿
Immobilized anti-I-A antibodies induce rapid morphologic transformation by IL-4-
and anti-l+-primed B cells. Quiescent (p >1.080) BDFl B cells (106/ml) were primed for 16hwith
IL-4 (100 U/ml)and anti-WmAb (Bet-2, 10 Wg/ml)before being transferred (with primary stimuli)
to uncoated plates (A), anti-H-2K, (Mi.42.398, 10 l+g/ml) coated plates (B), or anti-l-A (D3.137,
10 wg/ml) coated plates (C). After -12 h incubation at 37 °C, photomicrographs (x400) were
taken of representative fields. Results are representative of approximately 50 experiments .
1A andB) evenwhen plates were coated with fourfold more anti-H-2K than anti-Ia
(data not shown) .
We next determined whetherprimed B cellsenter cell cycle, proliferate, and differen-
tiate to secrete Ig in response to anti-la binding . Cells were primed as before and
transferred to antibody-coated or uncoated plates, and cultured for various times
before cell cycle analysis was performed by flow cytometric analysis following acri-
dine orange staining . Hydroxyureawasincluded in some cultures to blockdaughter
cell generation (22), thus allowing determination of the absolute frequency of cells
that entered cell cycle. As can be seen in Fig . 2A in these cultures, -95% ofprimed
cells exhibited significantly increased RNA content, indicative ofentry into Gi, 48 h
after transfer to anti-Ia-coated plates . Some increase in G1 phase cells was seen in
populationscultured with IL-4 plus anti-14 on either uncoated or anti-H-2K-coated
plates compared with cells primed with only IL-4 . These findings suggest that while
the combination of IL-4 and the monoclonal anti-,u provide all necessary signals
to stimulate entry ofa small percentage (N15%) ofB cells into Gt, the further ad-
dition of an Ia-mediated signal stimulates mostmembers of the population to enter
cell cycle . It should be noted that inclusion of higher doses of Bet-2 anti-j . (350 Wg/ml)
in cultures did not result in a significant increase in the percentage of cells that en-
tered cycle on anti-H-2K-coated plates.
Cell cycle analysis ofprimed cellscultured for48hon immobilized anti-lawithout
hydroxyurearevealed that anti-Ia stimulated progressionofmany cellsthrough cell
cycle . Shown in Fig. 3 is an isometric display of data generated by flow cytometric
analysis ofacridine orange stainedcells. Integrationofcellscontaining hyperdiploid
DNA (cells in channels >30 on the DNA axis) revealed that ti32% of cells were in880
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FIGURE 2 . IL-4 and anti-A-
primed B cells respond to im-
mobilized Iabinding ligands by
entry into cell cycle, prolifera-
tion, and differentiation to se-
crete IgM and IgG . Quiescent
BDF1 B cells (p <1.080) 106/ml)
were primedfor 16 hand stimu-
lated as described in Fig . 1 be-
fore analysis of entry into cell
cycle (A) after an additional
48 h, and [3H]thymidine up-
take (B) after an additional
24-96 h of culture. Alterna-
tively, cells were washed after
48 h incubation on antibody-
coated plates, and recultured for
72 h(on antibody-coatedplates)
in the lymphokine mixtures (100
U IL-4/ml, 200 U IL-5/ml,
20% vol/vol MLR supernatant)
indicated before Ig production
wasassessed (C). Shown inAare
RNA histograms generated by
flow cytometric analysis ofacri-
dine orange-stained cells that
had been primed as in Fig. 1
and cultured with 20 mM
hydroxyurea (Hu) andIL-4 on
uncoated plates (-)with Hu,
anti-W and IL4 on anti-H-2K
coated plates (- - -) with Hu,
anti-,u and IL4 on anti-I-A
coated plates ( . . . . . ) . Data are
representative ofthree separate
experiments. Shown in B are
time course analyses of thymi-
dine uptake by cells stimulated
with optimal concentration of
LPS (20 fig/ml) under culture
conditions described in Fig . 1
except that no IL-4 or anti-,u
was present, and cells were cultured on uncoated plates (p) . Alternatively, anti-w- and IL-4-primed
cells were cultured on uncoated (A), anti-H-2K-coated (O), or anti-I-A-coated (") plates . Shown are
mean andSD of assays oftriplicate cultures. Data are representative ofsix separate experiments. Shown
inCare IgM and IgG levels in cultures ofquiescentB cells that hadbeen primed with IL-4 and anti-W,
transferred (with stimuli) to anti-I-A, anti-H-2K, or uncoated plates for 48 h, and then washed three
times and recultured an additional 72 h with the lymphokines indicated, before IgM and IgG levels
were assayed using an ELISA . Control response to LPSwere 168 fig/ml IgM and 96,ag/ml IgG . Data
are representative of three separate experiments .
S, G2, orM at the time of analysis . By extropolation from cell cycle progression
rates seen in lymphomas, these findings predict that a large proportion (>70%)
of cells were proliferating. As an alternative assay of proliferation, we analyzed
[3H]thymidine incorporation uptake in companion cultures . As shown in Fig . 2 B,
IL-4 plus anti-,u-primed, anti-Ia-stimulated cells exhibited [3H]thymidine incor-
poration comparable to LPS-stimulated cells . Further, IL-4 plus anti-j-primed cells
did not incorporate significant [3H]thymidine if cultured on anti-H-2K-coated orCAMBIER AND LEHMANN
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FIGURE 3 .
￿
Anti-Ia antibodies stimulate progression ofprimedB cells through cell cycle. Quies-
cent BDFl cells were primed for 16 h before being transferred to anti-Ia-coated plates (D3.137)
as described in Fig . 1 . Cells were harvested and stained with acridine orange 48 h later, and
then analyzed by flow cytometry. Shown is an isometric display constructed based on analysis
of 20,000 cells . The display illustrates the relative number of cells at each coordinate ofRNA
(red fluorescence) andDNA(green fluorescence) content. These data are representative of five
replicate experiments .
uncoated plates . Thus, although IL-4 and monoclonal anti-A (Bet-2) promote entry
ofsome B cells into GI (Fig. 2 A), these cells apparently do not proceed into S phase
without an additional signal(s), i.e ., that provided by immobilized anti-Ia .
Next we assessed the ability of immobilized anti-Ia to stimulate Ig production
by primed B cells . In these experiments, quiescent B cells were primed for 16 h as
before, and cultured for 48 h (growth phase) on anti-Ia-coated plates . Cells were
then washed three times and recultured with IL-4 and IL-5 but without anti-iA . 72 h
later, supernatants were harvested and assayed for Ig content . As shown in Fig . 2
C, anti-Ia but not anti-H-2K, when used in combination with IL-4 and IL-5, provided
all signals necessary to support differentiation ofprimed cells tobecome Ig secretors.
However, this response wasmuch less than that inducedbyLPS (see Fig. 2 C, legend).
Further, significant Ig productionwas not seen in the absence of lymphokines (data
not shown) . Supplementation ofcultures during the final 72h with a mixedlympho-
cyte culture (15) supernatant known to contain additional lymphokines, resulted in
an approximate 10-fold increase in production ofIgM and IgG. In preliminary ex-
periments, we have attempted to reconstitute this response with various combina-
tions ofpurified and/or recombinantmouse IL-1, IL-2, IL-4, IFN-y, IL-5, andhuman
IL-6 but have thus far failed (data not shown) . These findings are consistent with
the possibilities that an additional lymphokine is necessary for induction ofdifferen-882
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tiation or that thelymphokinesused work optimally only when provided in acertain
sequence or a certain ratio.
To assure that the effects of anti-Ia in our experiments were a function of ligand
binding to la and not a result of some peculiar crossreactivity of the D3.137 anti-
I-Adb mAb with some other cell surface marker, we compared the ability of a
number of anti-Ia antibodies to induce primed B cells to proliferate. As shown in
Fig. 3, immobilized anti-Ia specific for I-E, I-Aß chain, and I-Aa chain exhibited
a comparable ability to induce proliferation . Thus, ligand binding to either I-E or
I-A ((x or ß chains) results in signaling . It should be noted that D3.137 anti-Iadb
did not stimulate Iak B cells (data not shown) .
Finally, we assessed the specificity of the response to anti-Ia by comparing the
ability of immobilizedmAbs specific for a variety ofB cell surface markers to acti-
vate primed B cells . In this experiment, activation was assessed based on theMTT
assay of mitochondrial metabolic activity (24) since this assay has proven to be the
most sensitive indicator of Ia mediated signaling. As shown in Fig . 4, antibodies
specific for Fc receptor (a rat IgG), IgD (a rat IgG), H-2K (a rat IgG), Lyb8 (a
mouse IgG1), and Lyb2 (a mouse IgG2b) did not stimulate primed B significantly
compared to anti-Ia . Surprisingly, anti-B220 (a rat IgM) exhibited significant stimula-
tory activity . We have subsequently observed that antibodies against a variety of
otherB cell markers includingJ11D (a ratIgM), anti-Qa2 (amouse IgM) and anti-
CD23 (a rat IgG) do not induce this response (data not shown) . Companion experi-
ments demonstrated that anti-B220 stimulates 60-80% of primed cells to undergo
morphologic transformation indistinguishable from that described in Fig . 1, how-
ever, this ligand does not stimulate significant thymidine incorporation (data not
shown) . These findings are particularly interesting in view of recent evidence that
CD45 is associated with atyrosine phosphatase activity (37) consistent with its (CD45)
functioning as a signal transducer.
The data presented demonstrate that immobilized Ia binding ligands stimulate
proliferation ofsmallB cellsprimed by contactwith IL-4 and membrane Ig binding
FIGURE 4 . Multiple anti-I-A
antibodies stimulated prolifer-
ation of primed B cells. Quies-
cent B cells were isolated from
ÀKRmice andprimed for 16 h
with IL-4 and anti-,u as
described in Fig. 1 . Cells were
then transferred to plates that
hadbeen coatedwith varied con-
centrations of anti-I-E (/,
14.4.4S), anti-I-A ß(A, 10.3.6;
0, 10.2.16 ; 0, 40M; and 0,
39F), or anti-I-Act (A, 2A2) an-
tibodies and cultured for 48 h
before [sH]thymidine uptake
was assessed . Data are repre-
sentative of three separate ex-
periments .CAMBIER AND LEHMANN
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FIGURE 5.
￿
Specificity ofanti-I-A activation ofprimed
B cells. QuiescentB cells were prepared from BDFl mice
and primed for 16h with 114 and anti-p as described
in Fig . 1 before being transferred to 96-well plates that
hadbeen precoated with 10 pg/ml monoclonal anti-Ly8
(Cy34.1 .2), anti-I-A (133.137), anti-Lyb2 (10-1.13.2), anti-
I-E (14.4.45), anti-B220 (RA3-3A1/69), anti-H-2K
(M1.42.398), anti-IgD (JA12.5), or anti-Fcr (2.4G2), or
were not precoated. After an additional 48 h incubation,
activation was assessed using theMTT assay. Shown
are themean t standard deviation oftriplicate cultures .
Data are representative of four separate experiments .
ligands. Basedon thesedata,we hypothesizethat IL-4, produced as aresult ofantigen-
presentingmacrophageTh cell interaction, and antigenprovidethe firstB cell signals
leading to "thymus-dependent" humoral immune responses . This combination of
signals induces quiescent B cells to become competent to interact directly with the
Th cell . This competence is probably a function, at least in part, of increased Ia
expression induced by IL-4 and antigen (20) . The physical interaction ofTh cells
and B cells results in turn in T cell signaling via a/3/CD3 binding to antigen/Ia,
andB cell signaling viaCD4 (7) binding to Ia. The primary involvement of CD4
binding to monomorphic Ia determinants in mediating this signal would explain
the ability ofTh cells to activate histo-incompatibleB cells, provided antigen-presenting
histo-compatible B cells are also present (22, 39) . B cell signaling mediated through
Ia molecules results in entry of most cells into cycle and proliferation, and prepares
the cells to differentiate to secrete Ig provided appropriatelymphokinesare present .
We believe that it is the lack ofthe Ia-mediated signal that has resulted in the previous
failure to achieve comparable activation of quiescent B cells in the presence of an-
tigen and lymphokines versus antigen and Th cells (12, 22, 35, 36, 39) .
Summary
One of the most controversial questions in immunology is the molecular basis
bywhichTh lymphocytesdeliver activating signals to quiescent B lymphocytesduring
T cell-dependent immune responses. Recent studies suggest that T cell-dependent
activation of quiescentB lymphocytes may involve signaling mediated by directT
helper cell-B cell contact . Since B cell membrane-associated MHC-encoded class
II molecules (Ia) must be recognized byTh lymphocytes forgeneration ofTcell-de-
pendent humoral immune responses, they are obvious candidates for receptors of
this signal . Here we report that stimulation of quiescent murine B cells with IL-4
andantibodies againsttheBcell antigen receptor for 12-16 hprimes cells to proliferate
in response to immobilized mIa bindingligands. In thepresence ofadditional lym-
phokines, theseB cells differentiate to secrete Ig ofIgM andIgGclasses. These results
suggest that Ia molecules are receptors for direct, T helper cell-B cell contact medi-
ated signaling that results in B cell proliferation.
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Kotzin and Philippa Marrack for helpful discussions .
Receivedfor publication 6 March 1989 and in revisedform 15 May 1989.884
￿
Ia-MEDIATED SIGNAL TRANSDUCTION
References
1 . Leclercq, L ., J . C . Cambier, Z . Mishel, M . H . Julius, and J . J . Theze . 1986 . Superna-
tants from a cloned helper T cell stimulates most small resting B cells to undergo in-
creased I-A expression, blastogenesis and progression through cell cycle . j . Immunol.
136:539.
2 . Brian, A. A . 1988. Stimulation of B-cell proliferation by membrane-associated mole-
cules from activated T cells. Proc. Nad . Acad Sci . USA. 85:564.
3 . Krusemeier, M ., andC . Snow. 1988. Induction oflymphokine responsiveness of hapten-
specificB lymphocytes promoted through an antigen-mediatedT helper lymphocyte in-
teraction . J Immunol . 140:367 .
4 . Riedel, C ., T Owens, and G. J . V. Nossal . 1988 . A significant proportion of normal
resting B cells are induced to secrete immunoglobulins through contact with anti-receptor
antibody-activated helper T cells in clonal cultures . Eur . ,j. Immunol. 18:403 .
5 . Hirohata, S., D. F. Jelinek, and P E . Lipsky. 1988 . T cell-dependent activation ofB cell
proliferation and differentiation by immobilized monoclonal antibodies toCD3 .j . Im-
munol. 140:3736.
6 . Owens, T 1988 . A noncognate interaction with anti-receptor antibody-activated helper
T cells induce small resting murine B cells to proliferate and to secrete antibody. Eur;
J. Immunol . 18:395 .
7 . Doyle, C ., andJ . L . Strominger. 1987 . Interaction betweenCD4 and class IIMHC mol-
ecules mediates cell adhesion . Nature (Loud.) . 330:256 .
8 . Cambier, J . C .,M . K . Newell, L . B . Justement,J . C . McGuire, K . L. Leach, and Z . Z .
Chen. 1987 . Ia binding ligands and cAMP stimulate nuclear translocation of PKC in
B lymphocytes. Nature (Lond).327 :629 .
9 . Niederhuber, J . E ., J . A . Frelinger, E . Dugan, A . Coutinho, and D. C . Shreffler. 1975 .
Effects of anti-Ia serum on rnitogenic responses . I. Inhibition of proliferative response
to B cell mitogen, LPS, by specific anti-la sera . J Immunol. 115:1672 .
10 . Forsgren, S ., G . Pobor, A . Coutinho, andM . Pierres . 1984 . The role ofI-A/E molecules
in B lymphocyte activation I. Inhibition oflipopolysaccharide-induced responses by mono-
clonal antibodies . ,j . Immunol . 133:2104 .
11 . Bishop,G. A., andG. Haughton. 1986. Induction ofdifferen
of Lyl' B cells by clonal T cells and antibodies. Proc. Nad. Acad. Sci. USA. 83:7410 .
12 . Julius, M., H . Von Boehmer, and C . L . Sidman . 1982 . Discussion of two signals re-
quired for activation of resting B cells . Proc. Nail . Acad . Sci. USA . 79:1989 .
13 . Karasuyama, H ., and R . Melchers . 1988 . Establishment of mouse cell lines which con-
stitutively secrete large quantitations ofinterleukin, 2, 3, 4, or 5, using modified cDNA
expression vector. ,j . Immunol. 18:98 .
14 . Roehm, N . W., J . L . Leibson, A . Zlotnik, J . Kappler, P Marrack, and J . C. Cambier.
1984 . Interleukin-induced increase in Ia expression by normal mouse B cells.f . Exp.
Med. 160:679 .
15 . L.M . Bradley. 1980. Mixed lymphocyte responses . In Selected Methods in Cellular Im-
munology. B . Mishall andH . Shiigi, editors .W H . Freeman andCo., San Francisco. 152 .
16 . Kung, J . T, S. O. Sharrowm, D. G. Sieckman, R . Lieberman, andW. E . Paul. 1981 .
A mouseIgM allotypic determinant (Igh 51b) recognized by a monoclonal rat antibody.
,J . Immunol. 127:872.
17 . Springer, T A. 1980 . Cell-surface differentiation in the mouse. In Monoclonal Antibodies.
R . H . Kennett, T J . McKearn, and K . B. Bechtol, editors . Plenum Press, New York .
185-217 .
18 . Pierres, M ., F. M . Kourlisky, J . P Rebouah, M . Dosset, and D . Caillol . 1980 . Distinct
epitopes on lk gene products identified by monoclonal antibodies. Eur . f. Immunol . 10:950.
19 . Beck, B . N ., J . M . Beurstedde, C . J . Krco, A. E . Nislon, C. G. Chase, D. J . McKean.CAMBIER AND LEHMANN
￿
885
1986. Characterization of cell lines expressing mutant I-Ab and I-Ak molecule allows the
definition ofdistinct serologic epitopes on Aa and AO polypeptides.J Immunol. 136:2953 .
20. Cambier,J. C., Z. Z. Chen, J. Pasternak, J. Ransom, V. Sandoval, and H . Pickles. 1988.
Ligand-induced desensitization of B-cell membrane immunoglobulin-mediated Cat*
mobilization and protein kinase C translocation. Proc. Nail. Acad. Sci. USA. 85:6493.
21 . Unkeless,J. D. 1979. Characterization ofa monoclonal antibody directed against mouse
macrophages and lymphocyte Fc receptors. J. Exp. Med. 150:580.
22 . Cambier, J. C., and M . H . Julius. 1987. Early changes in quiescent B cell physiology
subsequent to cognate and bystander interaction with helper T cells. Scand. J. Immunol.
27 :59.
23 . Epstein, R., K. Lehmann, and M. Cohn. 1983. Induction of'Y1 immunoglobulin is de-
termined by a regulatory gene (ryl) linked (or identical) to the structural (c-yl) gene.
J. Exp. Med. 157 :1681.
24. Mossman, T. 1983. Rapid colorimetric assay for cellular growth and survival: applica-
tion to proliferation and cytotoxicity assay. J. Immunol. Methods. 65 :55.
25 . Sanders, V. M., R. Fernandez-Botran, J. W. Uhr and E. S. Vitetta. 1987. Interleukin 4
enhances the ability of antigen-specific B cells to form conjugates with T cells. J Im-
munol. 139:2349.
26. Snapper, C. M., and W. E. Paul. 1987 . B cell stimulator factor-1 (interleukin 4) prepares
resting murine B cells to secrete IgG, upon subsequent stimulation with bacterial lipo-
polysaccharide. J. Immunol. 139:10.
27. Oliver, K., R. Noelle,J. W. Uhr, P. H. Krammer, and E. S. Vitetta. 1985. B-cell growth
factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentia-
tion factor for resting B cells and may not induce cell growth. Proc. Nail. Set. USA. 82:2465.
28. Wilson, H. A., D. Greenblatt, M. Peonie, F. D. Finkleman, R. Y. Tsien. 1987. Cross-
linkage ofB lymphocyte surface immunoglobulin by anti-Ig or antigen induced prolonged
oscillation of intracellular ionized calcium. J Exp. Med. 166:601.
29. Grupp, S. H., E. C. Snow, A. K. Harmony. 1987. Phosphatidylinositol response is an
early event in physiology relevant activation of antigen specific B lymphocytes. Cell. Im-
munol. 181 :1090.
30. Monroe, J. G., andJ. C. Cambier. 1983. B cell activation. III. B cell plasma membrane
depolarization and hyper I-A antigen expression induced by receptor immunoglobulin
crosslinking are coupled. J. Exp. Med. 158:1589.
31 . Snow, E. C.,J. D. Fetherston, and S. Zimmes. 1986. Induction of the c-myc after antigen
binding to hapten-specific B cells. J. Exp. Med. 164:944.
32 . Mizuguchi, J., W. Tsang, S. L. Morrison, M. A. Beavan, and W. E. Paul. 1986. Mem-
brane IgM, IgD and IgG act as signal transmission molecules in a series ofB lymphomas.
J Immunol. 137 :2162.
33 . Gold, M. R., J. P Jakway, and A. L. DeFranco. 1987. Involvement ofa guanine nucleotide-
binding component in membrane IgM-stimulated phosphoinositide breakdown. J. Im-
munol. 139:3604.
34. Cambier, J. C., C. H. Heusser, and M. H. Julius. 1986. Abortive activation of B lym-
phocytes by anti-immunoglobulin antibodies. J. Immunol. 136:3140.
35 . Cambier, J. C., J. G. Monroe, and M. J. Neale. 1982. Definition of conditions which
facilitate antigen specific activation of the majority of isolated trinitrophenol binding
B cells. J. Exp. Med. 156:1635.
36. Noelle, R. J., E. C. Snow, J. W. Uhr, and E. S. Vitetta. 1983 . Activation of antigen-
specific B cells: the role of T cells, cytokines and antigens in the induction of growth
and differentiation. Proc. Nail. Acad. Sci. USA. 80:6628.
37. Tonks, N. K., H . Charbonneau, C . D. Diltz, E. H. Fischer, and K. A. Walsh. 1988.
Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phospha-886
￿
la-MEDIATED SIGNAL TRANSDUCTION
tase. Biochemistry. 27:8697.
38 . Noelle, R., P H. Krammer, T. Ohara, J. W Uhr, and E. S. Vitetta. 1984. Increased
expression of la antigens on resting B cells: An additional role for B cells growth factor.
Proc. Natl. Acad. Sci. USA. 81 :6149.
39 . DeFranco, A. L., J. D. Ashwell, R. H. Schwartz, and W E. Paul. 1984. Polyclonal stimu-
lation of resting B lymphocytes by antigen specific T lymphocytes.j Exp. Med. 159:861.